JMP Securities raised the firm’s price target on Dave (DAVE) to $115 from $75 and keeps an Outperform rating on the shares. Dave’s ...

JMP Securities lowered the firm’s price target on OptimizeRx (OPRX) to $8 from $16 and keeps an Outperform rating on the shares.

Fintel reports that on November 13, 2024, JMP Securities downgraded their outlook for Syros Pharmaceuticals (NasdaqGS:SYRS) ...

JMP Securities raised the firm’s price target on Atlanticus (ATLC) to $54 from $45 and keeps an Outperform rating on the ...

On Wednesday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $2.66 which represents a decrease of $-0.18 or -6.34% from the prior close of $2.84. The stock opened at $2.88 and ...

JMP Securities lowered the firm’s price target on Angi Inc. (ANGI) to $3 from $3.25 and keeps an Outperform rating on the ...

Fintel reports that on November 11, 2024, JMP Securities downgraded their outlook for agilon health (NYSE:AGL) from Market ...

On Wednesday, Nerdy Inc (NRDY) stock saw a decline, ending the day at $0.82 which represents a decrease of $-0.08 or -8.89% from the prior close of $0.9. The stock opened at $0.89 and touched a low of ...

Financial giants have made a conspicuous bullish move on CrowdStrike Holdings. Our analysis of options history for ...

Ibotta posted third-quarter adjusted earnings of 94 cents per share, which may not compare to market estimates of 35 cents ...

Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report)‘s stock had its “market outperform” rating reissued by equities researchers at JMP Securities in a report issued on Tuesday,Benzinga reports. They ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...